Specifically, the AXIN2 rs2240308 (C > T) variant has been assessed and associated with several cancers (15–20); for breast cancer, this variant have been studied only in two different populations, although with inconsistent results (20, 22). This evidence concerns the gene AXIN2 and cancer.